Skip to main content
main-content

Type 2 diabetes and glycemic control

medwireNews top story

Haptoglobin genotype may dictate success of intensive glucose control

Blood test

The benefits and harms of intensive glucose control in people with type 2 diabetes may depend on which form of haptoglobin they have, shows an analysis of the ACCORD trial.

Expert opinion

Exposure to diabetes technologies: Where now for adult services?

Exposure to diabetes technologies: Where now for adult services?

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England. 

Get more on: Devices and technology | Pediatric diabetes

medwireNews editor's pick

Adding second diabetes medication better than switching in face of poor response

Addition

Adding an additional glucose-lowering medication is better than switching to a different one in people with type 2 diabetes, even if the original seemed to have little or no effect, shows an analysis from the MASTERMIND consortium.

Expert opinion editorial

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetologist Amar Puttanna addresses growing concerns about the rise of dementia in diabetes care and highlights where guidelines, research efforts, and management options are needed to tackle this comorbidity [read more].

Get more on: Mental health and diabetesDiabetes complications and comorbidities | Diabetes in older adults

medwireNews top story

d-Nav system helps people with type 2 diabetes optimize insulin doses

Compass

The d-Nav system, which calculates insulin dose adjustments according to glucose levels, can help people with type 2 diabetes achieve larger reductions in glycated hemoglobin levels than with healthcare professional support alone, shows a randomized trial in The Lancet.

medwireNews editor's pick

Hepatic glucokinase activation may improve glycemic control in type 2 diabetes

Pills_yellow

The hepatoselective glucokinase activator TTP399 reduces glycated hemoglobin levels without increasing the risk for hypoglycemia among patients with type 2 diabetes, suggest findings from the phase IIb AGATA trial.

Interactive patient case study

Hypoglycemia and technology

Hypoglycemia and technology

This 15-minute case presents the identification of problematic hypoglycemia and the appropriate use and monitoring of different technologies in the context of reducing the occurrence and risk of hypoglycemia.

Get more on: Hypoglycemia | Devices and technology | Pediatric diabetes

medwireNews editor's pick

Improved oral health could help glycemic control in type 2 diabetes

Oral health

A year of intensive periodontal treatment is associated with a significant reduction in glycated hemoglobin levels in patients with type 2 diabetes and moderate-to-severe periodontitis, UK researchers report.

medwireNews editor's pick

ADA/EASD consensus report on managing hyperglycemia in type 2 diabetes published

Best practice

The final version of the 2018 update to the consensus guidelines on managing hyperglycemia in people with type 2 diabetes is now published.

medwireNews editor’s pick

Promising phase II data for dual GIP and GLP-1 receptor agonist

Subcutaneous injection_arm

A compound that stimulates the receptors for both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 has dose-dependent effects on glucose levels and bodyweight in people with type 2 diabetes.

medwireNews

05-15-2020 | Inpatient diabetes | News

End of hospital stay glucose variability indicates readmission likelihood

People with diabetes who have high glucose variability on the last day of a hospital stay are at increased risk for being readmitted within 30 days, shows a US nationwide study.

05-11-2020 | Hypertension | News

Mixed effect of DBP on SBP reduction benefits in type 2 diabetes

Baseline diastolic blood pressure does not influence the cardiovascular gains from reducing systolic blood pressure in people with type 2 diabetes using a standard glucose-lowering regimen, indicates a secondary analysis of ACCORD data.

04-17-2020 | Insulin glargine | News

Similar glycemic control with glargine U300, U100 for inpatients with type 2 diabetes

Hospitalized people with poorly controlled type 2 diabetes who are treated with insulin glargine U300 have comparable glycemic control to those given the U100 formulation, and may have a lower risk for hypoglycemia, researchers report.

Downloadable slides

10-31-2018 | Slideset | Collection

FreeStyle Libre collection

These slide sets summarize the results of randomized controlled trials investigating the use of flash glucose-sensing technology in patients with diabetes.

Funded by an educational grant from Abbott Diabetes Care

Themed collections

07-31-2017 | Metabolic surgery | Themed collection | Collection

Metabolic surgery in diabetes

This content collection examines the mechanisms associated with diabetes remission following bariatric (metabolic) surgery, considers the patients most suitable for each procedure, and reviews post-surgical management and outcomes, including complications.

Journal articles and book chapters

11-06-2018 | Diabetes self-management | Article

Exploring how patients understand and assess their diabetes control

Gopalan A et al. BMC Endocr Disord 2018; 18: 79. doi: 10.1186/s12902-018-0309-4

11-03-2018 | Liraglutide (T2DM) | Article

Liraglutide and glycemic outcomes in the LEADER trial

Zinman B et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0524-z

09-14-2018 | Insulin glargine/Lixisenatide | Article

Bedtime-to-morning glucose difference and iGlarLixi in type 2 diabetes: Post hoc analysis of LixiLan-L

Zisman A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0507-0

09-13-2018 | Pathophysiology | Review | Article

Altered gut microbiota in type 2 diabetes: Just a coincidence?

Sircana A et al. Curr Diab Rep 2018; 18: 98. doi: 10.1007/s11892-018-1057-6

09-05-2018 | Older adults | Review | Article

Diabetes treatment in the elderly: Incorporating geriatrics, technology, and functional medicine

Valencia WM et al. Curr Diab Rep 2018; 18: 95. doi: 10.1007/s11892-018-1052-y

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

Image Credits